I.R. NURIEV, A.Y. ZUBKOV, E.N. SITDYKOV

Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012

Nuriev I.R. — postgraduate student of Urology Department, tel. +7-917-396-22-05, e-mail: ilyasrustamovich@mail.ru

Zubkov A.Y. — Cand. Med. Sc., Associate Professor of Urology Department, tel. (843) 236-88-73, e-mail: j-key@mail.ru

Sitdykov E.N. — D. Med. Sc., Professor of Urology Department, tel. (843) 236-76-47, e-mail sitdikovaM@telebit.ru

The article presents the analysis of the structure of postoperative complications after resection of the bladder in 42 patients for muscle-invasive cancer, depending on the stage, location of the tumor in combination with adjuvant intravesical chemotherapy.On the basis of the obtained data are estimated the indications for resection of the bladder in the treatment of muscle-invasive cancer, as well as proposed methods for the prevention of complications in the postoperative period.

Key words: bladder cancer, bladder resection, chemotherapy, complications.

REFERENCES

1. Apolikhin O.I. Kakorina E.P., Sivkov A.V. et. al. The condition of urological diseases in the Russian Federation, according to official statistics. Urology, 2008, vol. 3, pp. 3–9 (in Russ.).

2. Pereversev A.S., Petrov S.B. Bladder tumors. Kharkiv: Fact, 2002. 303 p.

3. Summary of guidelines of the European Association of Urology. Ed. by prof. Kogan M.I. 2009. 307 p.

4. Waehre H. Ous S. Klevmark B. et al. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cаncer. Cancer, 1993, vol. 72, pp. 3044-3051.

5. Bloom H.J.G., Hendry W.F., Wallase D.M., Skeet R.G. Treatment of T3 bladder cancer: controlled trial of preoperative radiotherapy and radical cystectomy versus radical radiotherapy. Brit. J. Urol., 1982, vol. 54, no. 2, pp. 136-151.

6. Hope-Stone H.F., Oliver R.T.D., England H.R., Blandy J.P. T3 bladder cancer: salvage rather then elective cystectomy after radiotherapy. Urology, 1984, vol. 24, no. 4, pp. 315-320.

7. Matveev B.P., Figurin K.M., Karjakin O.B. Rak mochevogo puzyrya [Bladder cancer]. Moscow: Verdana, 2001. 244 p.

8. Dunst J., Sauer R., Schrott K.M. et al. An organ sparing treatment of advanced bladder cancer: A 10-year experience. Int. J. Radiat. Oncol. Biol. Phys., 1994, vol. 30, pp. 261-266.

9. Colvett K.T., Althausen A.F., Bassil B. et al. Opportunities with combined modality therapy for selectiveorgan preservation in muscle-invasive bladdercancer. J. Surg. Oncol., 1996, vol. 63, no. 3, pp. 201-208.

10. Rödel C., Grabenbauer G.G., Kühn R. et al. Organ preservation in patients with invasive bladder cancer: initialresults of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Int. J. Rad. Oncol. Biol. Phis., 2002, vol. 52, no. 5, pp. 1303-1309.

11. Kogan M.I., Perepechai V.A. Current diagnosis and surgery for bladder cancer. Rostov-on-Don, 2002. 242 p.

12. Advanced Bladder Cancer (ABC) Metaanalysis Cjllaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. Eur. Urol., 2005, vol. 48 (2), pp. 202-205.

13. Henry K., Miller J., Mori M. et al. Comparison of transurethral resection to radical therapies for stage bladder tumors. J. Urol. 1988, vol. 140, p. 964.

14. Sweeny P., Kursh E.D., Resnick M.I. Partial cystectomy. Urol. Clin. North Am., 1992. vol. 19, pp. 10701-10711.

15. Given R.W., Wajsman Z. Bladder sparing treatments for muscle-invasive transitional cell carcinoma of the bladder. AUA Update Series, 1997, vol. 16, pp. 41-48.

16. Stackl W., Baierlein M., Albrecht W. Bladder preservation in muscle-invasive bladder cancer. Br. J. Urol., 1998, vol. 82, pp. 357-360.

17. Sitdykov E.N., Ibatullin I.A., Muhametshin I.G. Pat. №649414 USSR Method of pelvic puncturing and draining [A method of puncturing and draining pelvic]. Appl. 07/01/75; Publ. 02/28/79. Bull. No. 8 P. 30 (in Russ.).